Home300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Nakaraang pagsara
¥14.10
Sakop ng araw
¥13.89 - ¥14.13
Sakop ng taon
¥12.93 - ¥23.45
Market cap
15.75B CNY
Average na Volume
12.82M
P/E ratio
102.91
Dividend yield
-
Primary exchange
SHE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 645.20M | 42.85% |
Gastos sa pagpapatakbo | 424.14M | 38.76% |
Net na kita | 22.43M | -58.51% |
Net profit margin | 3.48 | -70.93% |
Kita sa bawat share | — | — |
EBITDA | 127.47M | 2.48% |
Aktuwal na % ng binabayarang buwis | 17.00% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 219.94M | -77.94% |
Kabuuang asset | 14.25B | -5.10% |
Kabuuang sagutin | 4.57B | -15.33% |
Kabuuang equity | 9.68B | — |
Natitirang share | 1.12B | — |
Presyo para makapag-book | 1.63 | — |
Return on assets | 0.86% | — |
Return on capital | 1.07% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 22.43M | -58.51% |
Cash mula sa mga operasyon | -46.30M | 39.22% |
Cash mula sa pag-invest | -65.23M | 82.73% |
Cash mula sa financing | -98.94M | -180.59% |
Net change in cash | -210.53M | 36.40% |
Malayang cash flow | -2.72B | -245.41% |
Tungkol
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Itinatag
Set 8, 1992
Website
Mga Empleyado
1,913
